{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:47:47Z","timestamp":1780418867086,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA043139"],"award-info":[{"award-number":["R01DA043139"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institue on Alcohol Abuse and Alcoholism","award":["K24AA025703"],"award-info":[{"award-number":["K24AA025703"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Mental health and substance use disorders disproportionately affect people with HIV (PWH), and may have been exacerbated during COVID-19. The Promoting Access to Care Engagement (PACE) trial was designed to assess the effectiveness of electronic screening for mental health and substance use in HIV primary care and enrolled PWH from October 2018 to July 2020. Our objective here was to compare screening rates and results for PWH before (October 2018 \u2013 February 2020) and early in the COVID-19 pandemic (March-July 2020).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Adult (\u2265\u200918 years) PWH from 3 large HIV primary care clinics in a US-based integrated healthcare system were offered electronic screening online or via in-clinic tablet computer every 6 months. Screening completion and results (for depression, suicidal ideation, anxiety, and substance use) were analyzed using logistic regression with generalized estimating equations to estimate prevalence ratios (PR) before and after the start of the regional COVID-19 shelter-in-place orders on March\u00a017, 2020. Models adjusted for demographics (age, sex, race\/ethnicity), HIV risk factors (men who have sex with men, injection drug use, heterosexual, other), medical center, and modality of screening completion (online or tablet). We conducted qualitative interviews with providers participating in the intervention to evaluate how the pandemic impacted patient care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 8,954 eligible visits, 3,904 completed screenings (420 during COVID,\u00a03,484 pre-COVID), with lower overall completion rates during COVID (38% vs. 44%). Patients completing screening during COVID were more likely to be White (63% vs. 55%), male (94% vs. 90%), and MSM (80% vs., 75%). Adjusted PRs comparing COVID and pre-COVID (reference) were 0.70 (95% CI), 0.92 (95% CI), and 0.54 (95% CI) for tobacco use, any substance use, and suicidal ideation, respectively. No significant differences were found by era for depression, anxiety, alcohol, or cannabis use. These results were in contrast to provider-reported impressions of increases in substance use and mental health symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Findings suggest PWH had modest declines in screening rates early in the COVID-19 pandemic which may have been affected by the shift to telemedicine. There was no evidence that mental health problems and substance use increased for PWH in primary care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>NCT03217058 (First registration date: 7\/13\/2017);<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03217058\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03217058<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1186\/s12913-023-09477-6","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T11:02:27Z","timestamp":1684234947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic"],"prefix":"10.1186","volume":"23","author":[{"given":"Alexandra N.","family":"Lea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tory M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Davy-Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Leibowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Altschuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Flamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bradley","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"N. Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek D.","family":"Satre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"9477_CR1","doi-asserted-by":"crossref","unstructured":"Koenig LJ, Khurana N, Islam MH, Gopalappa C, Farnham PG. Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the United States. AIDS. 2023. Mar 6. Epub ahead of print.","DOI":"10.1097\/QAD.0000000000003536"},{"issue":"2","key":"9477_CR2","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1016\/S2352-3018(22)00361-7","volume":"10","author":"A Bershteyn","year":"2023","unstructured":"Bershteyn A, Richard E, Zhou Q, Khan MR, Scheidell JD, Manandhar-Sasaki P, et al. Potential health benefits of integrated screening strategies for alcohol, tobacco, other substance use, depression, anxiety, and chronic pain among people living with HIV in the USA: a mathematical modelling study. Lancet HIV. 2023;10(2):e118\u2013e25.","journal-title":"Lancet HIV"},{"issue":"11","key":"9477_CR3","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/apc.2010.0139","volume":"24","author":"GN DeLorenze","year":"2010","unstructured":"DeLorenze GN, Satre DD, Quesenberry CP, Tsai AL, Weisner CM. Mortality after diagnosis of psychiatric disorders and co-occurring substance use disorders among HIV-infected patients. AIDS Patient Care STDS. 2010;24(11):705\u201312.","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"9477_CR4","doi-asserted-by":"publisher","first-page":"ofz188","DOI":"10.1093\/ofid\/ofz188","volume":"6","author":"NE Chichetto","year":"2019","unstructured":"Chichetto NE, Kundu S, Freiberg MS, Butt AA, Crystal S, So-Armah KA, et al. Association of Syndemic Unhealthy Alcohol Use, cigarette use, and Depression with all-cause mortality among adults living with and without HIV infection: Veterans Aging Cohort Study. Open Forum Infect Dis. 2019;6(6):ofz188.","journal-title":"Open Forum Infect Dis"},{"key":"9477_CR5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3389\/fpsyt.2020.00700","volume":"11","author":"S Zaami","year":"2020","unstructured":"Zaami S, Marinelli E, Var\u00ec MR. New Trends of substance abuse during COVID-19 pandemic: an International Perspective. Front Psychiatry. 2020;11:700.","journal-title":"Front Psychiatry"},{"issue":"6","key":"9477_CR6","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1097\/ADM.0000000000000755","volume":"14","author":"DD Satre","year":"2020","unstructured":"Satre DD, Iturralde E, Ghadiali M, Young-Wolff KC, Campbell CI, Leibowitz AS, et al. Treatment for anxiety and Substance Use Disorders during the COVID-19 pandemic: Challenges and strategies. J Addict Med. 2020;14(6):e293\u2013e6.","journal-title":"J Addict Med"},{"key":"9477_CR7","unstructured":"World Health Organization. Mental Health and COVID-19: Early evidence of the pandemic\u2019s impact. 2022. WHO\/2019-nCoV\/Sci_Brief\/Mental_health\/2022.1. Accessed April 26, 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1"},{"key":"9477_CR8","unstructured":"National Institute on Drug Abuse. COVID-19 & Substance Use. 2022 [updated February 25, 2022. Accessed April 26, 2022. Available from: https:\/\/nida.nih.gov\/drug-topics\/comorbidity\/covid-19-substance-use"},{"issue":"8","key":"9477_CR9","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3906\/sag-2006-140","volume":"50","author":"\u00d6 Kuman Tun\u00e7el","year":"2020","unstructured":"Kuman Tun\u00e7el \u00d6, Pulluk\u00e7u H, Erdem HA, Kurtaran B, Ta\u015fbakan SE, Ta\u015fbakan M. COVID-19-related anxiety in people living with HIV: an online cross-sectional study. Turk J Med Sci. 2020;50(8):1792\u2013800.","journal-title":"Turk J Med Sci"},{"issue":"6","key":"9477_CR10","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1007\/s10461-021-03547-8","volume":"26","author":"CE Parisi","year":"2022","unstructured":"Parisi CE, Varma DS, Wang Y, Vaddiparti K, Iba\u00f1ez GE, Cruz L, et al. Changes in Mental Health among People with HIV during the COVID-19 pandemic: qualitative and quantitative perspectives. AIDS Behav. 2022;26(6):1980\u201391.","journal-title":"AIDS Behav"},{"issue":"11","key":"9477_CR11","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1007\/s10461-020-02854-w","volume":"24","author":"AW Carrico","year":"2020","unstructured":"Carrico AW, Horvath KJ, Grov C, Moskowitz JT, Pahwa S, Pallikkuth S, et al. Double Jeopardy: Methamphetamine Use and HIV as Risk factors for COVID-19. AIDS Behav. 2020;24(11):3020\u20133.","journal-title":"AIDS Behav"},{"issue":"2","key":"9477_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s10461-020-02976-1","volume":"25","author":"KR Hochstatter","year":"2021","unstructured":"Hochstatter KR, Akhtar WZ, Dietz S, Pe-Romashko K, Gustafson DH, Shah DV, et al. Potential influences of the COVID-19 pandemic on Drug Use and HIV Care among People living with HIV and Substance Use Disorders: experience from a pilot mHealth intervention. AIDS Behav. 2021;25(2):354\u20139.","journal-title":"AIDS Behav"},{"issue":"3","key":"9477_CR13","doi-asserted-by":"publisher","first-page":"e26060","DOI":"10.1002\/jia2.26060","volume":"26","author":"C Hong","year":"2023","unstructured":"Hong C, Queiroz A, Hoskin J. The impact of the COVID-19 pandemic on mental health, associated factors and coping strategies in people living with HIV: a scoping review. J Int AIDS Soc. 2023;26(3):e26060.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"9477_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11524-022-00607-9","volume":"99","author":"M Javanbakht","year":"2022","unstructured":"Javanbakht M, Rosen A, Ragsdale A, Richter EI, Shoptaw S, Gorbach PM. Interruptions in Mental Health Care, Cannabis Use, Depression, and anxiety during the COVID-19 pandemic: findings from a cohort of HIV-Positive and HIV-Negative MSM in Los Angeles, California. J Urban Health. 2022;99(2):305\u201315.","journal-title":"J Urban Health"},{"key":"9477_CR15","doi-asserted-by":"publisher","first-page":"109233","DOI":"10.1016\/j.drugalcdep.2021.109233","volume":"231","author":"S Meanley","year":"2022","unstructured":"Meanley S, Choi SK, Thompson AB, Meyers JL, D\u2019Souza G, Adimora AA, et al. Short-term binge drinking, marijuana, and recreational drug use trajectories in a prospective cohort of people living with HIV at the start of COVID-19 mitigation efforts in the United States. Drug Alcohol Depend. 2022;231:109233.","journal-title":"Drug Alcohol Depend"},{"key":"9477_CR16","doi-asserted-by":"publisher","first-page":"109382","DOI":"10.1016\/j.drugalcdep.2022.109382","volume":"241","author":"JD Pytell","year":"2022","unstructured":"Pytell JD, Shen NM, Keruly JC, Lesko CR, Lau B, Fojo AT, et al. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; a cross-sectional survey of people enrolled in collaborating Consortium of cohorts producing NIDA Opportunities (C3PNO) cohorts. Drug Alcohol Depend. 2022;241:109382.","journal-title":"Drug Alcohol Depend"},{"key":"9477_CR17","doi-asserted-by":"publisher","first-page":"105833","DOI":"10.1016\/j.cct.2019.105833","volume":"84","author":"DD Satre","year":"2019","unstructured":"Satre DD, Anderson AN, Leibowitz AS, Levine-Hall T, Slome S, Flamm J, et al. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: protocol for the promoting Access to Care Engagement (PACE) trial. Contemp Clin Trials. 2019;84:105833.","journal-title":"Contemp Clin Trials"},{"issue":"5","key":"9477_CR18","doi-asserted-by":"publisher","first-page":"e2110721","DOI":"10.1001\/jamanetworkopen.2021.10721","volume":"4","author":"J McNeely","year":"2021","unstructured":"McNeely J, Adam A, Rotrosen J, Wakeman SE, Wilens TE, Kannry J, et al. Comparison of methods for Alcohol and Drug Screening in Primary Care clinics. JAMA Netw Open. 2021;4(5):e2110721.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"9477_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"key":"9477_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.genhosppsych.2015.11.005","volume":"39","author":"F Plummer","year":"2016","unstructured":"Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24\u201331.","journal-title":"Gen Hosp Psychiatry"},{"issue":"12","key":"9477_CR21","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s11136-015-1040-5","volume":"24","author":"L Spangenberg","year":"2015","unstructured":"Spangenberg L, Glaesmer H, Boecker M, Forkmann T. Differences in Patient Health Questionnaire and Aachen Depression Item Bank scores between tablet versus paper-and-pencil administration. Qual Life Res. 2015;24(12):3023\u201332.","journal-title":"Qual Life Res"},{"issue":"10","key":"9477_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.7326\/M16-0317","volume":"165","author":"J McNeely","year":"2016","unstructured":"McNeely J, Wu LT, Subramaniam G, Sharma G, Cathers LA, Svikis D, et al. Performance of the Tobacco, Alcohol, prescription medication, and other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Ann Intern Med. 2016;165(10):690\u20139.","journal-title":"Ann Intern Med"},{"issue":"2","key":"9477_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"key":"9477_CR24","first-page":"189","volume-title":"Qualitative methods in Aging Research","author":"M Luborsky","year":"1994","unstructured":"Luborsky M. The identification and analysis of themes and patterns. In: Gubrium JF, Sankar A, editors. Qualitative methods in Aging Research. New York, NY: Sage; 1994. pp. 189\u2013210."},{"issue":"9","key":"9477_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245\u201351.","journal-title":"Acad Med"},{"issue":"6","key":"9477_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"10","key":"9477_CR27","doi-asserted-by":"publisher","first-page":"e2021476","DOI":"10.1001\/jamanetworkopen.2020.21476","volume":"3","author":"GC Alexander","year":"2020","unstructured":"Alexander GC, Tajanlangit M, Heyward J, Mansour O, Qato DM, Stafford RS. Use and Content of Primary Care Office-Based vs Telemedicine Care visits during the COVID-19 pandemic in the US. JAMA Netw Open. 2020;3(10):e2021476.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"9477_CR28","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1007\/s10461-022-03607-7","volume":"26","author":"EE Friedman","year":"2022","unstructured":"Friedman EE, Devlin SA, Gilson SF, Ridgway JP. Age and racial disparities in Telehealth Use among People with HIV during the COVID-19 pandemic. AIDS Behav. 2022;26(8):2686\u201391.","journal-title":"AIDS Behav"},{"issue":"Suppl 6","key":"9477_CR29","doi-asserted-by":"crossref","first-page":"e25810","DOI":"10.1002\/jia2.25810","volume":"24","author":"KA McGinnis","year":"2021","unstructured":"McGinnis KA, Skanderson M, Justice AC, Akg\u00fcn KM, Tate JP, King JT Jr, et al. HIV care using differentiated service delivery during the COVID-19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs. J Int AIDS Soc. 2021;24(Suppl 6):e25810.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"9477_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/apc.2019.0261","volume":"34","author":"D Dandachi","year":"2020","unstructured":"Dandachi D, Dang BN, Lucari B, Teti M, Giordano TP. Exploring the attitude of patients with HIV about using Telehealth for HIV Care. AIDS Patient Care STDS. 2020;34(4):166\u201372.","journal-title":"AIDS Patient Care STDS"},{"issue":"2","key":"9477_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11904-021-00543-4","volume":"18","author":"JZ Budak","year":"2021","unstructured":"Budak JZ, Scott JD, Dhanireddy S, Wood BR. The impact of COVID-19 on HIV Care provided via Telemedicine-Past, Present, and Future. Curr HIV\/AIDS Rep. 2021;18(2):98\u2013104.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"9","key":"9477_CR32","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/hiv.13299","volume":"23","author":"KW Lee","year":"2022","unstructured":"Lee KW, Ang CS, Lim SH, Siau CS, Ong LTD, Ching SM, et al. Prevalence of mental health conditions among people living with HIV during the COVID-19 pandemic: a rapid systematic review and meta-analysis. HIV Med. 2022;23(9):990\u20131001.","journal-title":"HIV Med"},{"issue":"3","key":"9477_CR33","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1097\/QAI.0000000000002564","volume":"86","author":"M Pizzirusso","year":"2021","unstructured":"Pizzirusso M, Carrion-Park C, Clark US, Gonzalez J, Byrd D, Morgello S. Physical and Mental Health Screening in a New York City HIV Cohort during the COVID-19 pandemic: a preliminary Report. J Acquir Immune Defic Syndr. 2021;86(3):e54\u2013e60.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"9477_CR34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/09540121.2021.1975628","volume":"34","author":"M Pantelic","year":"2022","unstructured":"Pantelic M, Martin K, Fitzpatrick C, Nixon E, Tweed M, Spice W, et al. I have the strength to get through this using my past experiences with HIV\u201d: findings from a mixed-method survey of health outcomes, service accessibility, and psychosocial wellbeing among people living with HIV during the Covid-19 pandemic. AIDS Care. 2022;34(7):821\u20137.","journal-title":"AIDS Care"},{"issue":"11","key":"9477_CR35","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1007\/s10461-021-03292-y","volume":"25","author":"J Diaz-Martinez","year":"2021","unstructured":"Diaz-Martinez J, Tamargo JA, Delgado-Enciso I, Liu Q, Acu\u00f1a L, Laverde E, et al. Resilience, anxiety, stress, and substance use patterns during COVID-19 pandemic in the Miami Adult Studies on HIV (MASH) Cohort. AIDS Behav. 2021;25(11):3658\u201368.","journal-title":"AIDS Behav"},{"issue":"4","key":"9477_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1097\/QAI.0000000000002680","volume":"87","author":"JA Tamargo","year":"2021","unstructured":"Tamargo JA, Martin HR, Diaz-Martinez J, Trepka MJ, Delgado-Enciso I, Johnson A, et al. COVID-19 testing and the impact of the pandemic on the Miami Adult Studies on HIV Cohort. J Acquir Immune Defic Syndr. 2021;87(4):1016\u201323.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"9477_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/09540121.2011.608795","volume":"24","author":"JM Hormes","year":"2012","unstructured":"Hormes JM, Gerhardstein KR, Griffin PT. Under-reporting of alcohol and substance use versus other psychiatric symptoms in individuals living with HIV. AIDS Care. 2012;24(4):420\u20133.","journal-title":"AIDS Care"},{"issue":"2","key":"9477_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/alcalc\/agp091","volume":"45","author":"PA Shuper","year":"2010","unstructured":"Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J. Causal considerations on alcohol and HIV\/AIDS\u2013a systematic review. Alcohol Alcohol. 2010;45(2):159\u201366.","journal-title":"Alcohol Alcohol"},{"key":"9477_CR39","volume-title":"The case for behavioral health screening in HIV Care Settings. HHS publication no SMA-16-4999","author":"Substance Abuse and Mental Health Services Administration ahd Helath Resources and Services Administration","year":"2016","unstructured":"Substance Abuse and Mental Health Services Administration ahd Helath Resources and Services Administration. The case for behavioral health screening in HIV Care Settings. HHS publication no SMA-16-4999. Rockville, MD: substance Abuse and Mental Health Services Administration; 2016."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-09477-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T02:03:19Z","timestamp":1702432999000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09477-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9477"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-09477-6","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,16]]},"assertion":[{"value":"25 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Waivers of informed consent and HIPAA authorizations were obtained for the data only portion by Kaiser Permanente Northern California and University of California, San Francisco Institutional Review Boards and study procedures were approved by Kaiser Permanente Northern California and University of California, San Francisco Institutional Review Boards. Verbal informed consent was obtained from providers participating in the qualitative interviews and no compensation was provided for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"494"}}